| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2019.06.013 |
| P698 | PubMed publication ID | 31331772 |
| P2093 | author name string | Leigh F Johnson | |
| Cari van Schalkwyk | |||
| Alex Welte | |||
| Jennifer Moodley | |||
| P2860 | cites work | Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial | Q28236008 |
| Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials | Q30970916 | ||
| The potential impact of HPV-16 reactivation on prevalence in older Australians. | Q33769284 | ||
| An updated natural history model of cervical cancer: derivation of model parameters | Q34083083 | ||
| Sexual behaviour in context: a global perspective | Q34580899 | ||
| The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model | Q35038766 | ||
| The known unknowns of HPV natural history | Q35578583 | ||
| Seroconversion Following Anal and Genital HPV Infection in Men: The HIM Study | Q36376432 | ||
| Evidence and impact of human papillomavirus latency | Q36540628 | ||
| Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis | Q36745242 | ||
| Immunosuppression facilitates the reactivation of latent papillomavirus infections | Q37547649 | ||
| Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women | Q37626453 | ||
| A Comparison of Two Mathematical Modeling Frameworks for Evaluating Sexually Transmitted Infection Epidemiology | Q37837556 | ||
| Episodic detection of human papillomavirus within a longitudinal cohort of young women | Q37840105 | ||
| Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme | Q38110696 | ||
| Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study | Q38599579 | ||
| Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach. | Q39553749 | ||
| Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era. | Q39601038 | ||
| Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark | Q39882847 | ||
| Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women | Q40603173 | ||
| Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years | Q40743154 | ||
| Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study | Q41753328 | ||
| High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. | Q43584971 | ||
| Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom | Q43961793 | ||
| Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. | Q45477958 | ||
| Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. | Q46129985 | ||
| Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity | Q47363184 | ||
| The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. | Q51490108 | ||
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. | Q52745312 | ||
| Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign | Q56518363 | ||
| Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis | Q57089346 | ||
| Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection | Q88930162 | ||
| P433 | issue | 36 | |
| P921 | main subject | HPV vaccine | Q900189 |
| P304 | page(s) | 5460-5465 | |
| P577 | publication date | 2019-07-19 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions | |
| P478 | volume | 37 |
Search more.